S&P 500   2,719.99 (+2.11%)
DOW   23,210.46 (+2.34%)
QQQ   199.51 (+1.54%)
AAPL   263.74 (+0.48%)
FB   170.26 (+2.85%)
MSFT   166.77 (+0.91%)
GOOGL   1,197.00 (+1.17%)
AMZN   2,018.36 (+1.04%)
CGC   14.86 (+3.63%)
NVDA   265.64 (-1.03%)
BABA   199.44 (+1.52%)
MU   47.59 (+2.63%)
GE   7.27 (+0.41%)
TSLA   554.99 (+7.51%)
AMD   49.04 (+3.20%)
T   30.58 (+3.87%)
ACB   0.82 (+2.50%)
F   4.87 (+7.99%)
NFLX   375.65 (-1.13%)
BAC   22.61 (+5.70%)
GILD   74.82 (-3.74%)
DIS   103.13 (+3.56%)
S&P 500   2,719.99 (+2.11%)
DOW   23,210.46 (+2.34%)
QQQ   199.51 (+1.54%)
AAPL   263.74 (+0.48%)
FB   170.26 (+2.85%)
MSFT   166.77 (+0.91%)
GOOGL   1,197.00 (+1.17%)
AMZN   2,018.36 (+1.04%)
CGC   14.86 (+3.63%)
NVDA   265.64 (-1.03%)
BABA   199.44 (+1.52%)
MU   47.59 (+2.63%)
GE   7.27 (+0.41%)
TSLA   554.99 (+7.51%)
AMD   49.04 (+3.20%)
T   30.58 (+3.87%)
ACB   0.82 (+2.50%)
F   4.87 (+7.99%)
NFLX   375.65 (-1.13%)
BAC   22.61 (+5.70%)
GILD   74.82 (-3.74%)
DIS   103.13 (+3.56%)
S&P 500   2,719.99 (+2.11%)
DOW   23,210.46 (+2.34%)
QQQ   199.51 (+1.54%)
AAPL   263.74 (+0.48%)
FB   170.26 (+2.85%)
MSFT   166.77 (+0.91%)
GOOGL   1,197.00 (+1.17%)
AMZN   2,018.36 (+1.04%)
CGC   14.86 (+3.63%)
NVDA   265.64 (-1.03%)
BABA   199.44 (+1.52%)
MU   47.59 (+2.63%)
GE   7.27 (+0.41%)
TSLA   554.99 (+7.51%)
AMD   49.04 (+3.20%)
T   30.58 (+3.87%)
ACB   0.82 (+2.50%)
F   4.87 (+7.99%)
NFLX   375.65 (-1.13%)
BAC   22.61 (+5.70%)
GILD   74.82 (-3.74%)
DIS   103.13 (+3.56%)
S&P 500   2,719.99 (+2.11%)
DOW   23,210.46 (+2.34%)
QQQ   199.51 (+1.54%)
AAPL   263.74 (+0.48%)
FB   170.26 (+2.85%)
MSFT   166.77 (+0.91%)
GOOGL   1,197.00 (+1.17%)
AMZN   2,018.36 (+1.04%)
CGC   14.86 (+3.63%)
NVDA   265.64 (-1.03%)
BABA   199.44 (+1.52%)
MU   47.59 (+2.63%)
GE   7.27 (+0.41%)
TSLA   554.99 (+7.51%)
AMD   49.04 (+3.20%)
T   30.58 (+3.87%)
ACB   0.82 (+2.50%)
F   4.87 (+7.99%)
NFLX   375.65 (-1.13%)
BAC   22.61 (+5.70%)
GILD   74.82 (-3.74%)
DIS   103.13 (+3.56%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Evoke PharmaIterum TherapeuticsJaguar HealthMoleculin BiotechCitius Pharmaceuticals
SymbolNASDAQ:EVOKNASDAQ:ITRMNASDAQ:JAGXNASDAQ:MBRXNASDAQ:CTXR
Price Information
Current Price$1.09$2.72$0.47$0.57$0.67
52 Week RangeHoldHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyBuy
Consensus Price TargetN/A$10.33$4.00$2.50$5.50
% Upside from Price TargetN/A279.90% upside750.88% upside342.40% upside722.86% upside
Trade Information
Market Cap$27.38 million$39.09 million$25.83 million$29.28 million$23.44 million
Beta1.830.950.781.591.38
Average Volume169,52140,810262,9172,730,6451,186,981
Sales & Book Value
Annual RevenueN/A$40,000.00$4.42 millionN/AN/A
Price / SalesN/A949.285.44N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.18 per share($1.88) per share$5.80 per share$0.34 per share$0.84 per share
Price / BookN/A-1.450.08N/AN/A
Profitability
Net Income$-7,130,000.00$-103,130,000.00$-32,150,000.00$-13,200,000.00$-15,560,000.00
EPS($0.32)($7.10)($158.74)($0.32)N/A
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-771.25%N/AN/A
Return on Equity (ROE)-150.20%-880.10%-675.03%-87.56%-73.49%
Return on Assets (ROA)-110.82%-173.97%-94.64%-57.40%-61.72%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.61%0.02%N/A
Current Ratio3.10%0.32%0.88%3.78%0.78%
Quick Ratio3.10%0.32%0.61%3.78%0.78%
Ownership Information
Institutional Ownership Percentage6.02%50.66%0.35%10.20%2.18%
Insider Ownership Percentage13.16%51.10%1.81%11.20%56.84%
Miscellaneous
Employees6484097
Shares Outstanding24.23 million13.96 million51.15 million53.23 million31.49 million
Next Earnings Date5/13/2020 (Estimated)5/12/2020 (Estimated)5/19/2020 (Estimated)5/11/2020 (Estimated)5/20/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel